Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia: Long-term outcome in relation to acute electrophysiological findings

European Heart Journal

Volumn 23, Issue 5, 2002, Pages 414-424

  Della Bella, P ^a   De Ponti, R ^b   Uriarte, J A S ^b   Tondo, C ^a   Klersy, C ^c   Carbucicchio, C ^a   Storti, C ^c   Riva, S ^a   Longobardi, M ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Catheter ablation; Myocardial infarction; Ventricular tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL TRIAL; CORONARY HEMODYNAMICS; DEFIBRILLATOR; DOSE RESPONSE; FEMALE; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETREATMENT; SURVIVAL RATE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0036522222     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2804     Document Type: Article

References (32)

1. Stevenson WG, Khan H, Sager P et al. Identification of reentry circuit sites during catheter mapping and radio-frequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993; 88: 1647-70.
2. Wilber D.J, Kopp D.E, Glascock DN, Kinder CA, Kall JG Catheter ablation of the mitral isthmus for ventricular tachycardia associated with inferior infarction. Circulation 1995; 92: 3481-9.
3. Bogun F, Bahu M, Knight BE et al. Comparison of effective and ineffective target sites that demonstrate concealed entrainment in patients with coronary artery disease undergoing radiofrequency ablation of ventricular tachycardia. Circulation 1997; 95: 183-90.
4. Morady F, Harvey M, Kalbfleisch SJ, El-Atassi R, Calkins H, Langberg JJ Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993; 87: 363-72.
5. Kim YH, Sosa-Suarez G, Trouton TG et al. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation 1994; 89: 1094-102.
6. Gonska BD, Cao K, Schaumann A, Dorszewski A, Von Zur Muhlen F, Kreuzer H Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: Results and long-term follow-up. J Am Coll Cardiol 1994; 24: 1506-14.
7. Farré J, Rubio JM, Navarro F, Sanziani L, Rivas D, Romero J Current role and future perspectives for radiofrequency catheter ablation of postmyocardial infarction ventricular tachycardia. Am J Cardiol 1996; 78 (Suppl 5A): 76-88.
8. Rothman SA, Hsia HH, Cossù SF, Chmielewski IL, Buxton AE, Miller JM Radiofrequency catheter ablation of postinfarction ventricular tachycardia. Long-term success and the significance of inducible nonclinical arrhythmias. Circulation 1997; 96: 3499-508.
9. Stevenson WG, Friedman PL, Kocovic D, Sager PT, Saxon LA, Pavri B Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998; 98: 308-14.
10. Sarter BH, Finkle JK, Gerszten RE, Buxton AE What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol 1996; 28: 122-9.
11. Brugada P, Talajic M, Smeets J, Mulleneers R, Wellens HJJ The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Eur Heart J 1989; 10: 747-52.
12. DiMarco JP, Lerman BB, Kron IL, Sellers DT Sustained ventricular tachyarrhythmias within 2 months of acute myocardial infarction: Results of medical and surgical therapy in patients resuscitated from the initial episode. J Am Coll Cardiol 1985; 6: 759-68.
13. Miller JM, Kienzle MG, Harken AH et al. Subendocardial resection for ventricular tachycardia: Predictors of surgical success. Circulation 1984; 70: 624-31.
14. Nath S, Haines D, Hobson CE et al. Ventricular tachycardia surgery. J Cardiovasc Electrophysiol 1992; 3: 160-72.
15. Hargrove III WC, Addonizio VP, Miller JM Surgical therapy of ventricular tachyarrhythmias in patients with coronary artery disease. J Cardiovasc Electrophysiol 1996; 7: 469-80.
16. Raitt MH, Renfroe EG, Epstein AE et al. 'Stable' ventricular tachycardia is not a benign rhythm. Insights from the AVID registry. Circulation 2001; 103: 244-52.
17. Bocker D, Block M, Isbruch F et al. Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 1995; 73: 158-63.
18. Yusuf S, Wittles J, Friedman L Overview of results of randomized clinical trials in heart disease. JAMA 1988; 260: 2088-93.
19. Kendall MJ, Lynch KP, Hjalmarson A et al. Beta-blockers and sudden cardiac death. Ann Inter Med 1995; 123: 358-67.
20. Burkart F, Pfisterer M, Kiowski W et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel antiarrythmic study of infarct survival (BASIS). J Am Coll Cardiol 1990; 16: 1711-18.
21. Pfisterer ME, Kiowski W, Brunner H et al. Long term benefit of 1 year Amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation 1993; 87: 309-11.
22. Julian DG, Camm AJ, Franglin G, Janse MJ, Munoz A, Schwartz PJ for the European myocardial infarct Amiodarone trial investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349: 667-74.
23. Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone myocardial infarction arrhythmia trial investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675-82.
24. Sims I, McDonald KM, Lavori PW et al. Quantitative overview of randomized trials of Amiodarone to prevent sudden death. Circulation 1997; 96: 2823-9.
25. The antiarrhythmics versus implantable defibrillators (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83.
26. Sweeney MO, Ruskin JN Mortality benefits and the implantable cardioverter-defibrillator. Circulation 1994; 89: 1851-8.
27. Brooks R, Garan H, Torchiana D et al. Three-year outcome of a nonthoracotomy approach to cardioverter-defibrillator implantation in 189 consecutive patients. Am J Cardiol 1994; 74: 1011-15.
28. Schlepper M, Neuzner J, Pitschner HF Implantable cardioverter defibrillator: Effect on survival. PACE 1995; 18: 569-78.
29. Trappe HJ, Pfitzner P, Achtelik M, Fieguth HG Age dependent efficacy of implantable cardioverter defibrillator treatment: Observations in 450 patients over an 11 year period. Heart 1997; 78: 364-70.
30. Stevenson WG, Friedman PL, Sweeney MO Catheter ablation as an adjunct to ICD therapy (Editorial). Circulation 1997; 96: 1378-80.
31. Strickberger A, Man KC, Daoud EG et al. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary disease and an implantable cardioverter-defibrillator. Circulation 1997; 96: 1521-31.
32. Svenson RH, Litman L, Gallagher JJ et al. Termination of ventricular tachycardia with epicardial laser photocoagulation: A clinical comparison with patients undergoing successful endocardial photocoagulation alone. J Am Coll Cardiol 1990; 15: 163-70.